ACCESS Newswire

The newsfeed available here is provided by our content partner ACCESS Newswire. This is one of the most important and widest-reaching press services, providing news, press releases and multimedia content to the media, journalists and the public.

The NewsWire Hub ("X-Billboard") currently comprises five of the most important international news sources and is supplemented by a stock market information service. The individual newswire services complement each other and form a complementary information offering that covers more than three quarters of the official news sources on which editorial offices worldwide base their stock market reporting. Your advantage: You will find everything here in one overview. You can navigate to the individual sections using the control elements. In the terminal view, you can carry out individual searches at company level.
F&G: 63
6.451,83 S&P · 15,88 Vola-Index · 119.462,51 BTC · 1,16940 EURUSD
System-State: Number of processed items 15.673 Notifications successully processed since Inception
EXCHANGE NEWSBOARD
                              
NEWSWIRE INFOBOARD
                              

ACCESS Newswire is an important news source for private investors, investors and traders that can be accessed via the X-Billboard. It is part of the Newswire Hub, which bundles important international news sources for stock market players in one central location. If you want to get a quick overview, you can easily scroll through the headlines. Those who want to take a closer look at the news can use the detailed views of the info cards to directly access the respective news item and other analysis tools.

NEWS
EXPLORER
CA0909741062
State: 13.08.2025 | 9AM
Do you already know our new terminal view? Click here.
FIGI: BBG00PVP57Y6
BNXT

BioNxt Solutions Inc.
GICS: - · Sector: EQTY · Sub-Sector: -
NAME
BioNxt Solutions Inc.
ISIN
CA0909741062
TICKER
BNXT
MIC
XCNQ
REUTERS
BNXT.CD
BLOOMBERG
BNXT CN
Sun, 10.08.2025       BioNxt

VANCOUVER, BC / ACCESS Newswire / 5. August 2025 / BioNxt Solutions Inc. (CSE: BNXT)(OTC Markets: BNXTF) (FWB: BXT), ein auf innovative Arzneimittelverabreichungs-Technologien spezialisiertes Biowissenschaftsunternehmen, gibt mit großer Freude einen wichtigen Fortschritt in seinem internationalen Patent-Portfolio bekannt. Das Unternehmen hat s...
Fri, 08.08.2025       BioNxt

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESS Newswire / August 8, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC:BNXTF)(FSE:BXT), is pleased to announce today that it has closed the final tranche of its previously announced non‐...
Fri, 25.07.2025       BioNxt

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESS Newswire / July 25, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC:BNXTF)(FSE:BXT), is pleased to announce today that it has closed the first tranche of its previously announced non‐b...
Silent Ad
Wed, 23.07.2025       BioNxt

VANCOUVER, BC / ACCESS Newswire / 23. Juli 2025 / BioNxt Solutions Inc. („BioNxt" oder das „Unternehmen") (CSE: BNXT) (OTC PINK: BNXTF) (FWB: BXT), ein auf fortschrittliche Arzneimittelverabreichungssysteme spezialisierter Biowissenschaftsinnovator, freut sich, die erfolgreiche Formulierung des Prototypen eines sublingualen Schmelzfilms f...
Fri, 11.07.2025       BioNxt

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESS Newswire / July 11, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), is pleased to announce its intention to complete a non‐brokered private placement (the "O...
Tue, 08.07.2025       BioNxt

VANCOUVER, BC / ACCESS Newswire / July 8, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), a development-stage biopharmaceutical company specializing in advanced drug-delivery technologies, today announces the advancement of a potential breakthrough targeted chemotherapy delivery plat...
Mon, 07.07.2025       BioNxt

VANCOUVER, BC / ACCESS Newswire / 7. Juli 2025 / BioNxt Solutions Inc. („BioNxt" oder das „Unternehmen") (CSE: BNXT / OTC: XPHYF / FWB: 4XT), ein auf fortschrittliche Arzneimittelverabreichungssysteme spezialisierter Biowissenschaftsinnovator, freut sich, den Erhalt des aktiven pharmazeutischen Wirkstoffs (API) für seinen führen...
Fri, 27.06.2025       BioNxt

VANCOUVER, BC / ACCESS Newswire / June 27, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), is pleased to announce that effective immediately, the British Columbia Securities Commission has revoked the temporary management cease trade order ("MCTO") it had previously granted...
Mon, 23.06.2025       BioNxt

VANCOUVER, BC / ACCESS Newswire / June 23, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC:BNXTF)(FSE:BXT), is pleased to announce the launch of a feasibility study for the development of an oral dissolvable film (ODF) formulation of Semaglutide, a GLP-1 receptor agonist currently marketed globally under ...
Thu, 12.06.2025       BioNxt

VANCOUVER, BC / ACCESS Newswire / June 12, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:4XT), announces that, further to its news release dated May 1, 2025 (the "Default Announcement"), the Company's principal regulator, the British Columbia Securities Commission (the "BC...
Silent Ad
Thu, 29.05.2025       BioNxt

VANCOUVER, BC / ACCESS Newswire / May 29, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), announces that, further to its news release dated May 1, 2025 (the "Default Announcement"), the Company's principal regulator, the British Columbia Securities Commission (the "BCS...
Fri, 23.05.2025       BioNxt

VANCOUVER, BC / ACCESS Newswire / 23. Mai 2025 / BioNxt Solutions Inc. („BioNxt" oder das „Unternehmen") (CSE: BNXT) (OTC PINK: BNXTF) (FWB: BXT), ein auf fortschrittliche Arzneimittelverabreichungssysteme spezialisierter Biowissenschaftsinnovator, freut sich bekannt zu geben, dass die Prüfungsabteilung des Europäischen Patentam...
Thu, 15.05.2025       BioNxt

VANCOUVER, BC / ACCESS Newswire / May 15, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:XPHYF)(FSE:4XT), announces that, further to its news release dated May 1, 2025 (the "Default Announcement"), the Company's principal regulator, the British Columbia Securities Commission (the "BCS...
Thu, 15.05.2025       BioNxt

VANCOUVER, BC / ACCESS Newswire / 13. Mai 2025 / BioNxt Solutions Inc. („BioNxt" oder das „Unternehmen") (CSE: BNXT)(OTC PINK: BNXTF)(FWB: BXT), ein auf fortschrittliche Arzneimittelverabreichungssysteme spezialisiertes Biowissenschaftsunternehmen, freut sich bekannt zu geben, dass seine Forschungs-, Entwicklungs- und Vermarktungsaktivit&...
Mon, 05.05.2025       BioNxt

VANCOUVER, BC / ACCESS Newswire / 5. Mai 2025 / BioNxt Solutions Inc. („BioNxt" oder das „Unternehmen") (CSE: BNXT) (OTC PINK: BNXTF) (FWB: BXT), ein auf fortschrittliche Arzneimittelverabreichungssysteme spezialisierter Biowissenschaftsinnovator, freut sich bekannt zu geben, dass seine erste Patentanmeldung auf nationaler Ebene von der E...
Thu, 01.05.2025       BioNxt

VANCOUVER, BC / ACCESS Newswire / May 1, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC:BNXTF)(FSE:BXT), announces that its annual financial statements for the year ended December 31, 2024, the related management discussion and analysis, and certifications of the Chief Executive Officer (the "CEO&qu...
Wed, 23.04.2025       BioNxt

VANCOUVER, BC / ACCESS Newswire / 23. April 2025 / BioNxt Solutions Inc. („BioNxt" oder das „Unternehmen") (CSE: BNXT)(OTC PINK: BNXTF)(FWB: BXT), ein auf fortschrittliche Arzneimittelverabreichungssysteme spezialisierter Biowissenschaftsinnovator, freut sich, mitteilen zu können, dass die Vorbereitungen zu seiner Bioäquivalenzs...
Fri, 14.03.2025       BioNxt

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESS Newswire / March 14, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC:BNXTF)(FSE:BXT), is pleased to announce that, further to its news release of February 28, 2025, it has closed the f...
Fri, 28.02.2025       BioNxt

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESS Newswire / February 28, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:4XT), is pleased to announce today that it has closed the first tranche of its previously announ...
Mon, 24.02.2025       BioNxt

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESS Newswire / February 24, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:4XT), announces a non-brokered private placement of debenture units (the "Debenture Units&q...
Silent Ad

The information provided here is not subject to any editorial processing. It is prepared fully automatically and enriched with additional information and further research options. The aim of the content is to provide information seekers with the relevant information quickly and easily. A link back to the information provider and owner ensures that the data prepared here can be compared with the source information if required. The newsboard does not show information in real time. Please contact the exchange operator for this information if required. There is no claim to completeness. High availability cannot be guaranteed. If you notice any errors in the functionality, please let us know using the "Report a Bug" form below.

RAW DATA PROCESSING means that raw data is processed without changing the content. The data is supplemented to improve the interpretation of the information in terms of usability.

Note: The newswire crosslink panel in the upper area allows you to quickly and conveniently access additional sources of information. In the terminal view, the news is filtered at company level and enables targeted research.


On behalf of the international investor community, we would like to thank AccessWire for providing the news and data feeds

 

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S